SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-048573
Filing Date
2024-02-28
Accepted
2024-02-27 21:50:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d800854d424b5.htm 424B5 412051
2 GRAPHIC g800854g01l19.jpg GRAPHIC 59772
3 GRAPHIC g800854g22i26.jpg GRAPHIC 37808
  Complete submission text file 0001193125-24-048573.txt   543744
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266720 | Film No.: 24689871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)